161 related articles for article (PubMed ID: 30722822)
1. Clostridium histolyticum as first-line treatment of Dupuytren's disease.
Hartig-Andreasen C; Schroll L; Lange J
Dan Med J; 2019 Feb; 66(2):. PubMed ID: 30722822
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of collagenase treatment for Dupuytren's disease: 2-year follow-up results.
Van Beeck A; Van den Broek M; Michielsen M; Didden K; Vuylsteke K; Verstreken F
Hand Surg Rehabil; 2017 Oct; 36(5):346-349. PubMed ID: 28732844
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of collagenase Clostridium histolyticum injection for Dupuytren's contracture in East-Asian population.
Hatta T; Goto H; Sonofuchi K; Itoi E
J Orthop Sci; 2019 May; 24(3):431-433. PubMed ID: 30392715
[TBL] [Abstract][Full Text] [Related]
4. Collagenase injections for Dupuytren disease: 3-year treatment outcomes and predictors of recurrence in 89 hands.
Nordenskjöld J; Lauritzson A; Åkesson A; Atroshi I
Acta Orthop; 2019 Dec; 90(6):517-522. PubMed ID: 31500473
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of concurrent collagenase clostridium histolyticum injections for multiple Dupuytren contractures.
Coleman S; Gilpin D; Kaplan FT; Houston A; Kaufman GJ; Cohen BM; Jones N; Tursi JP
J Hand Surg Am; 2014 Jan; 39(1):57-64. PubMed ID: 24315486
[TBL] [Abstract][Full Text] [Related]
6. Short-term efficacy and safety of collagenase injection for Dupuytren's contracture: Therapy protocol for successful outcomes in a clinical setting.
Sakai A; Zenke Y; Menuki K; Yamanaka Y; Tajima T; Tsukamoto M; Uchida S
J Orthop Sci; 2019 May; 24(3):434-440. PubMed ID: 30392714
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of collagenase clostridium histolyticum injection for Dupuytren contracture: short-term results from 2 open-label studies.
Witthaut J; Jones G; Skrepnik N; Kushner H; Houston A; Lindau TR
J Hand Surg Am; 2013 Jan; 38(1):2-11. PubMed ID: 23218556
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture.
Badalamente MA; Hurst LC
J Hand Surg Am; 2007; 32(6):767-74. PubMed ID: 17606053
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of collagenase clostridium histolyticum in the treatment of proximal interphalangeal joints in dupuytren contracture: combined analysis of 4 phase 3 clinical trials.
Badalamente MA; Hurst LC; Benhaim P; Cohen BM
J Hand Surg Am; 2015 May; 40(5):975-83. PubMed ID: 25843533
[TBL] [Abstract][Full Text] [Related]
10. Outcome of Dupuytren Contractures After Collagenase Clostridium Histolyticum Injection: A Single-institution Experience.
Hwee YK; Park D; Vinas M; Litts C; Friedman D
Ann Plast Surg; 2017 Aug; 79(2):145-148. PubMed ID: 28604542
[TBL] [Abstract][Full Text] [Related]
11. Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
Hurst LC; Badalamente MA; Hentz VR; Hotchkiss RN; Kaplan FT; Meals RA; Smith TM; Rodzvilla J;
N Engl J Med; 2009 Sep; 361(10):968-79. PubMed ID: 19726771
[TBL] [Abstract][Full Text] [Related]
12. Collagenase injections for Dupuytren's disease: prospective cohort study assessing 2-year treatment effect durability.
Lauritzson A; Atroshi I
BMJ Open; 2017 Mar; 7(3):e012943. PubMed ID: 28298365
[TBL] [Abstract][Full Text] [Related]
13. Enzyme injection as nonsurgical treatment of Dupuytren's disease.
Badalamente MA; Hurst LC
J Hand Surg Am; 2000 Jul; 25(4):629-36. PubMed ID: 10913202
[TBL] [Abstract][Full Text] [Related]
14. Collagenase Clostridium Histolyticum Injection for Dupuytren Contracture: 2-Year Follow-up.
Nayar SK; Pfisterer D; Ingari JV
Clin Orthop Surg; 2019 Sep; 11(3):332-336. PubMed ID: 31475055
[TBL] [Abstract][Full Text] [Related]
15. Collagenase treatment of Dupuytren's contracture using a modified injection method: a prospective cohort study of skin tears in 164 hands, including short-term outcome.
Atroshi I; Nordenskjöld J; Lauritzson A; Ahlgren E; Waldau J; Waldén M
Acta Orthop; 2015 Jun; 86(3):310-5. PubMed ID: 25695745
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of Dupuytren's disease with collagenase - a 1-year follow-up of 37 patients].
Binter A; Neuwirth M; Rab M
Handchir Mikrochir Plast Chir; 2014 Dec; 46(6):355-60. PubMed ID: 25564949
[TBL] [Abstract][Full Text] [Related]
17. The Use of Residual Collagenase for Single Digits With Multiple-Joint Dupuytren Contractures.
Grandizio LC; Akoon A; Heimbach J; Graham J; Klena JC
J Hand Surg Am; 2017 Jun; 42(6):472.e1-472.e6. PubMed ID: 28389081
[TBL] [Abstract][Full Text] [Related]
18. Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data.
Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Tursi JP; Cohen B; Kaufman GJ; Lindau T
J Hand Surg Am; 2013 Jan; 38(1):12-22. PubMed ID: 23200951
[TBL] [Abstract][Full Text] [Related]
19. The use of Collagenase Clostridium Histolyticum in the management of Dupuytren's contracture-outcomes of a pilot study in a District General Hospital setting.
Murphy LE; Murphy KM; Kilpatrick SM; Thompson NW
Ulster Med J; 2017 May; 86(2):94-98. PubMed ID: 29535479
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Treatment Outcomes after Collagenase Injection and Percutaneous Needle Fasciotomy for Dupuytren's Contracture: Objective and Subjective Comparisons with a 3-Year Follow-Up.
Abe Y
Plast Reconstr Surg; 2020 Jun; 145(6):1464-1474. PubMed ID: 32459776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
